Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cells ; volume:17 ; number:1 ; day:11 ; month:12 ; year:2017 ; pages:1-11 ; date:12.2017
Cancer cell international ; 17, Heft 1 (11.12.2017), 1-11, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Qin, Yiyang
- Beteiligte Personen und Organisationen
-
Sekine, Ikuo
Fan, Mengmeng
Takiguchi, Yuichi
Tada, Yuji
Shingyoji, Masato
Hanazono, Michiko
Yamaguchi, Naoto
Tagawa, Masatoshi
SpringerLink (Online service)
- DOI
-
10.1186/s12935-017-0493-8
- URN
-
urn:nbn:de:1111-20180208711
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
17.02.1971, 00:18 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Qin, Yiyang
- Sekine, Ikuo
- Fan, Mengmeng
- Takiguchi, Yuichi
- Tada, Yuji
- Shingyoji, Masato
- Hanazono, Michiko
- Yamaguchi, Naoto
- Tagawa, Masatoshi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
Significant Clinical Benefit of Pemetrexed-based Chemotherapy for Advanced Diffuse Malignant Peritoneal Mesothelioma: A Case Presentation
Effect of renal function on pemetrexed-induced haematotoxicity
Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
Activity of pemetrexed in pre-clinical chordoma models and humans
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
Hedgehog pathway activation might mediate pemetrexed resistance in NSCLC cells
Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance
Second-line-Behandlung des malignen Pleuramesothelioms mit Pemetrexed (Alimta®) - eine Kasuistik
Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
Significant Clinical Benefit of Pemetrexed-based Chemotherapy for Advanced Diffuse Malignant Peritoneal Mesothelioma: A Case Presentation
Effect of renal function on pemetrexed-induced haematotoxicity
Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
Activity of pemetrexed in pre-clinical chordoma models and humans
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
Hedgehog pathway activation might mediate pemetrexed resistance in NSCLC cells
Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance
Second-line-Behandlung des malignen Pleuramesothelioms mit Pemetrexed (Alimta®) - eine Kasuistik
Molecular mechanism implicated in Pemetrexed-induced apoptosis in human melanoma cells
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
Significant Clinical Benefit of Pemetrexed-based Chemotherapy for Advanced Diffuse Malignant Peritoneal Mesothelioma: A Case Presentation
Effect of renal function on pemetrexed-induced haematotoxicity
Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report
The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma
Activity of pemetrexed in pre-clinical chordoma models and humans
Outcomes of Pemetrexed-based chemotherapies in HER2-mutant lung cancers
Hedgehog pathway activation might mediate pemetrexed resistance in NSCLC cells
Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance
Second-line-Behandlung des malignen Pleuramesothelioms mit Pemetrexed (Alimta®) - eine Kasuistik